They are sad alot.
They are angry alot.
They are shy.
They are quiet.
They keep their head down.
Depressed mood.
Inability to enjoy activities.
Problems concentrating.
Changes in eating habits or appetite.
Weight gain or weight loss.
Changes in sleeping habits.
Difficulty going to work or taking care of your daily responsibilities because of a lack of energy.
Feelings of guilt and hopelessness; wondering if life is worth living (common).
Slowed thoughts and speech.
Preoccupation with thoughts of death or suicide.
Complaints that have no physical cause (somatic complaints) such as headache and stomachache.
All of these symptoms can interfere with your quality of life. Even if you don't have major depression, if you have experienced a few of these symptoms for at least 2 weeks you may have a less severe form of depression that still requires treatment.
They have no freinds or are loosing freinds.
Suicidal thoughts.
These are all signs of deppression.
I reccommend taking Zooloft.
It worked for me.
See a doctor first though.
Depression (mood)
From Wikipedia, the free encyclopedia
Jump to: navigation, search
"Sad" redirects here. For other uses, see Sad (disambiguation).
"Sadness" redirects here. For the video game, see Sadness (video game).
Depression, or, more properly, a depressed mood, may in everyday English refer to a state of melancholia, unhappiness or sadness, or to a relatively minor downturn in mood that may last only a few hours or days. This is quite distinct from the medical diagnosis of clinical depression. However, if depressed mood lasts at least two weeks, and is accompanied by other symptoms that interfere with daily living, it may be seen as a symptom of clinical depression, dysthymia or some other diagnosable mental illness, or alternatively as sub-syndromal depression.
A depressed mood is generally situational and reactive, and associated with grief, loss, or a major social transition. A change of residence, marriage, divorce, the break-up of a significant relationship, graduation, or job loss are all examples of instances that might trigger a depressed mood.
In the field of psychiatry, the word depression can also have this meaning of low mood but more specifically refers to a mental illness when it has reached a severity and duration to warrant a diagnosis. The Diagnostic and Statistical Manual of Mental Disorders (DSM) states that a depressed mood is often reported as being: "... depressed, sad, hopeless, discouraged, or 'down in the dumps'." In a clinical setting, a depressed mood can be something a patient reports (a symptom), or something a clinician observes (a sign), or both.
Contents
1 Subjective experience of being depressed
1.1 Sadness
2 Determinants of mood
2.1 Environment
2.2 Psychological Factors
2.3 Physiological Considerations
3 Adaptive benefits of depression
4 Depressed mood in literature and culture
Subjective experience of being depressed
The feeling of depression is one of emotional suffering, sometimes seen as a mental analogue of physical pain. Someone who is depressed may be said to have a 'heavy heart', or if more seriously depressed be 'broken-hearted', because of a common sensation of the emotion in the chest. Other somatic expressions can be a sense of 'low spirits', a 'drag' or being weighed down, and a heaviness in breathing, expressed as despondent or dejected sighing. It may also be associated with apathy, boredom, emptiness and lack of any positive source of interest or joy.
Depression - in this non-medical sense - may be caused by a loss or personal failure (as in sadness), personal rejection, or indeed by any undesired outcome or situation, particularly if the situation happens or continues despite the efforts of the subject. In addition to sadness, there can in a depressed mood be a conscious resignation that the unpleasant situation is difficult to change. Usually whatever causes the state of depression is consciously recognised as the cause, which is not necessarily the case with longer-term clinical depression. Other conscious factors in maintaining depression may be loneliness and long-term stress.
External affective signs of depressed mood also include a physical hunching or stooping, or putting the head in the hands, and an appearance of being physically subdued, and flatness of speech. See also Dysphoria.
Sadness
Sadness and sorrow tend to refer to a feeling about specific events, whereas 'depression' can be a state of more generalised, and possibly chronic, gloom and despondency that is not relieved by companionship or hope. Sadness is more likely to involve weeping as an external sign, and the corresponding subjective experience of tension in the throat.
Determinants of mood
Depression can be the result of many factors, individually and acting in concert.
Environment
Reactions to events, often a loss in some form, are perhaps the most obvious causes. This loss may be obvious, such as the death of a loved one, or having moved from one house to another (mainly with children), or less obvious, such as disillusionment about one's career prospects. Monotonous environments can be depressing. A lack of control over one's environment can lead to feelings of helplessness. Domestic disputes and financial difficulties are common causes of a depressed mood. Love, or lack of being able to express your feelings can lead to a feeling of unexplainable sadness or grief.
Psychological Factors
Sometimes the depressed mood may relate more to internal processes or even be triggered by them. Pessimistic views of life or a lack of self-esteem can lead to depression. Illnesses and changes in cognition that occur in psychosis and dementias, to name but two, can lead to depression. Depression may also be comorbid with cardiovascular disorders. [1].
Physiological Considerations
A diathesis-stress model of depression (including clinical depression) is now widely accepted. This implies that underlying personality has some degree of influence over how the mood of individuals is affected by life events. The social, psychological and biological etiology of depression is still being actively investigated. The causal relationship with biological variables is unknown and so it is difficult to pinpoint the condition's roots. Some general physiological considerations include genetics (i.e. a hypothesised innate disposition to depression), neurochemistry (e.g. high levels of stress homones such as cortisol, low dopamine activity), sleep patterns, female hormone imbalance (e.g. PMS in women), male hormone imbalance (testosterone) in men, use of medication (e.g. corticosteroids), chronic illness (e.g. diabetes or hypothyroidism), and seasonal factors (e.g. seasonal affective disorder related to hormones and sunlight). See Clinical depression.
Adaptive benefits of depression
While a depressed mood is usually seen as deleterious, it may have adaptive benefits. The loss of a loved spouse, child, friend or relation, a physical illness or loss of lifestyle, tends to lead to feelings of depression. Freud noted the similarities between mourning and depression (then called melancholia) in a now famous paper entitled, "Mourning and Melancholia". The depressed mood is adaptive in that it leads the person towards altering their thought patterns and behavior or way of living or else continues until such a time as they do so. It can be argued that depression and clinical depression is in fact the refusal of a person to heed the call to change from within their own mind. For example, in mourning it is essential that one must eventually let go of the dead person and return to the world and other relationships.
Depression appears to have the effect of stopping a person in their tracks and forcing them to turn inwards and engage in a period of self reflection; it is a deeply introspective state. During this period, which can last anything from days to years, the individual must find a new way to interpret their thoughts and feelings and reassess the extent to which their appraisal of their reality is a valid one.
Seasonal affective disorder may point to an atavistic link with behaviour in hibernation.
Depressed mood in literature and culture
Unlike jealousy or anger, a mild depressed state is not intimately associated with a motive for action, and this is a likely reason for it being under-represented in drama. The journey of King Lear could be seen as a state of depression seeking forgiveness and redemption, although it is arguably pathological. Many of the works of Anton Chekhov, such as Uncle Vanya, involve either depressed mood or clinical depression. On the other hand, sorrow and regret perhaps occur much more commonly in literature, and tragedy, where the audience or readers may share to sadness or despair of the characters, is seen as one of the greatest of art forms and perhaps the most profound. The films and plays of Ingmar Bergman cover both bereavement (as in Virgin Spring) and depressed mood (Wild Strawberries).
One of the most famous examples of depression in literature is Goethe's The Sorrows of Young Werther, and for this reason it is referred to in Frankenstein. A similar example in music is Schubert's Winterreise, a setting of poems by Wilhelm Mueller. See also Melancholy.
A Pietà is an example of the representation of grief and sorrow in Christian art. Self-portraits of Frida Kahlo often show her depressed state. Many more examples could be added.
Clinical depression
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Depressive episode ICD-10 F32, F33 Recurrent depressive disorder
ICD-9 296.2 Single episode, 296.3 Recurrent, 296.5 Bipolar I disorder most recent episode depressed
Clinical depression is a state of sadness, melancholia or despair that has advanced to the point of being disruptive to an individual's social functioning and/or activities of daily living. Although a low mood or state of dejection that does not affect functioning is often referred to as depression, clinical depression is a medical diagnosis and is different from the everyday meaning of "being depressed".
Vincent van Gogh, who himself suffered from depression and commited suicide, painted this picture in 1890 of a man that can emblematise the desperation and hopelessness felt in depression.Contents [hide]
1 History
2 Prevalence
3 Diagnosis
3.1 Mnemonics
4 Types of depression
4.1 Major/Clinical Depression
4.2 Other Categories of Depression
5 The role of anxiety in depression
5.1 Anxiety
5.2 Hypomania
6 Causes of depression
7 Treatment
7.1 Medication
7.2 Dietary supplements
7.3 Augmentor drugs
7.4 Psychotherapy
7.5 Transcranial magnetic stimulation
7.6 Vagus nerve stimulation
7.7 Electroconvulsive therapy
7.8 Other methods of treatment
7.8.1 Light therapy
7.8.2 Exercise
7.8.3 Meditation
7.9 Old methods
8 Adverse reactions
9 Relapse
10 Social attitudes to depression
10.1 Employment
11 See also
12 Bibliography
12.1 Books by psychologists and psychiatrists
12.2 Books by people suffering or having suffered from depression
History
The Ebers papyrus (ca 1550 BC) contains a short description of clinical depression. Though full of incantations and foul applications meant to turn away disease-causing demons and other superstition, it also evinces a long tradition of empirical practice and observation.
The modern idea of depression appears similar to the much older concept of melancholia. The name melancholia derives from 'black bile', one of the 'four humours' postulated by Galen.
Clinical depression was originally considered to be a chemical imbalance in transmitters in the brain, a theory based on observations made in the 1950s of the effects of reserpine and isoniazid in altering monoamine neurotransmitter levels and affecting depressive symptoms [1]. Since these suggestions, many other causes for clinical depression have been proposed.
Prevalence
Clinical depression affects about 16%[2] of the population on at least one occasion in their lives. The mean age of onset, from a number of studies, is in the late 20s. About twice as many females as males report or receive treatment for clinical depression, though this imbalance is shrinking over the course of recent history; this difference seems to completely disappear after the age of 50 - 55, when most females have passed the end of menopause. Clinical depression is currently the leading cause of disability in the US as well as other countries, and is expected to become the second leading cause of disability worldwide (after heart disease) by the year 2020, according to the World Health Organization[3].
Diagnosis
The diagnosis may be applied when an individual meets a sufficient number of the symptomatic criteria for the depression spectrum as suggested in the DSM-IV-TR or ICD-9/ICD-10. An individual is often seen to suffer from what is termed a "clinical depression" without fully meeting the various criteria advanced for a specific diagnosis on the depression spectrum. There is an ongoing debate regarding the relative importance of genetic or environmental factors, or gross brain problems versus psychosocial functioning.
According to the DSM-IV-TR criteria for diagnosing a major depressive disorder one of the following two elements must be present (See the DSM cautionary statement.):
Depressed mood, or
Loss of interest or pleasure in nearly all activities.
It is sufficient to have either of these symptoms in conjunction with five of a list of other symptoms over a two-week period. These include
Feelings of overwhelming sadness or fear or the seeming inability to feel emotion (emptiness).
A decrease in the amount of interest or pleasure in all, or almost all, activities of the day, nearly everyday.
Changing appetite and marked weight gain or loss.
Disturbed sleep patterns, such as insomnia, loss of REM sleep, or excessive sleep.
psychomotor agitation or retardation nearly everyday.
Fatigue, mental or physical, also loss of energy.
Feelings of guilt, helplessness, hopelessness, anxiety, or fear.
Trouble concentrating or making decisions or a generalized slowing and obtunding of cognition, including memory.
recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide.
Other symptoms sometimes reported but not usually taken into account in diagnosis include
A decrease in self-esteem.
Inattention to personal hygiene.
Sensitivity to noise.
Physical aches and pains, and the belief these may be signs of serious illness.
Fear of 'going mad'.
Change in perception of time.
Depression in children is not as obvious as it is in adults. Here are some symptoms that children might display:
Loss of appetite.
Irritability.
Sleep problems, such as recurrent nightmares.
Learning or memory problems where none existed before.
Significant behavioral changes; such as withdrawal, social isolation, and aggression.
An additional indicator could be the excessive use of drugs or alcohol. Depressed adolescents are at particular risk of further destructive behaviors, such as eating disorders and self-harm.
One of the most widely used instruments for measuring depression severity is the Beck Depression Inventory, a 21-question multiple choice survey.
It is hard for people who have not experienced clinical depression, either personally or by regular exposure to people suffering it, to understand its emotional impact and severity, interpreting it instead as being similar to "having the blues" or "feeling down." As the list of symptoms above indicates, clinical depression is a serious, potentially lethal systemic disorder characterized by interlocking physical, affective, and cognitive symptoms that have consequences for function and survival well beyond sad or painful feelings.
Mnemonics
Mnemonics commonly used to remember the DSM-IV criteria are SIGECAPS[4] (sleep, interest (anhedonia), guilt, energy, concentration, appetite, psychomotor, suicidality) and DEAD SWAMP[5] (depressed mood, energy, anhedonia, death (thoughts of), sleep, worthlessness/guilt, appetite, mentation, psychomotor).
Types of depression
The diagnostic category major depressive disorder appears in the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association. The term is generally not used in countries which instead use the ICD-10 system, but the diagnosis of depressive episode is very similar to an episode of major depression. Clinical depression also usually refers to acute or chronic depression severe enough to need treatment. Minor depression is a less-used term for a subclinical depression that does not meet criteria for major depression but where there are at least two symptoms present for two weeks.
Major/Clinical Depression
Major Depression, or, more properly, Major Depressive Disorder (MDD), is characterized by a severely depressed mood that persists for at least two weeks, and is generally recognized to contain an organic (chemical) component [citation needed]. Major Depressive Disorder is specified as either "a single episode" or "recurrent"; periods of depression may occur as discrete events or as recurrent over the lifespan. Episodes of major or clinical depression may be further divided into mild, major or severe. Where the patient has already had an episode of mania or markedly elevated mood, a diagnosis of bipolar disorder (also called bipolar affective disorder) is usually made instead of MDD; depression without periods of elation or mania is therefore sometimes referred to as unipolar depression because their mood remains on one pole. The diagnosis also usually excludes cases where the symptoms are a normal result of bereavement.
Diagnosticians recognize several possible subtypes of Major Depressive Disorder. ICD-10 does not specify a melancholic subtype, but does distinguish on presence or absence of psychosis.
Depression with Catatonic Features - This subtype can be applied to Major Depressive episodes as well as to manic episodes, though it is rare, and rarer in mania. Catatonia is characterized by motoric immobility evidenced by catalepsy or stupor. This MDD subtype may also manifest excessive, nonprompted motor activity (akathisia), extreme negativism or mutism, and peculiarities in movement, including stereotypical movements, prominent mannerisms, and prominent grimacing. There may also be evidence of echolalia or echopraxia. It is very rarely encountered, and may not be a useful category.
Depression with Melancholic Features - Melancholia is characterized by a loss of pleasure (anhedonia) in most or all activities, a failure of reactivity to pleasurable stimuli, a quality of depressed mood more pronounced than that of grief or loss, a worsening of symptoms in the morning hours, early morning waking, psychomotor retardation, anorexia (excessive weight loss, not to be confused with Anorexia Nervosa), or excessive guilt.
Depression with Atypical Features - Atypicality is characterized by mood reactivity (paradoxical anhedonia) and positivity, significant weight gain or increased appetite, excessive sleep or somnolence (hypersomnia), leaden paralysis, or significant social impairment as a consequence of hypersensitivity to perceived interpersonal rejection. People with this can react with interest or pleasure to some things, unlike most depressed individuals.
Depression with Psychotic Features - Some people with Major Depressive or Manic episode may experience psychotic features. They may be presented with hallucinations or delusions that are either mood-congruent (content coincident with depressive themes) or non-mood-congruent (content not coincident with depressive themes). It is clinically more common to encounter a delusional system as an adjunct to depression than to encounter hallucinations, whether visual or auditory.
Other Categories of Depression
Dysthymia is a long-term, mild depression that lasts for a minimum of two years. There must be persistent depressed mood continuously for at least two years. By definition the symptoms are not as severe as with Major Depression, although those with Dysthymia are vulnerable to co-occurring episodes of Major Depression. This disorder often begins in adolescence and crosses the lifespan. People who are diagnosed with major depressive episodes and dysthymic disorder are diagnosed with double depression. Dysthimic disorder develops first and then one or more major depressive episodes happen later.
Bipolar I Disorder is an episodic illness in which moods may cycle between mania and depression. In the United States, Bipolar Disorder was previously called Manic Depression. This term is no longer favored by the medical community, however, even though depression plays a much stronger (in terms of disability and potential for suicide) role in the disorder. "Manic Depression" is still often used in the nonmedical community.
Bipolar II Disorder is an episodic illness that is defined primarily by depression but evidences episodes of hypomania.
Postpartum Depression or Post-Natal Depression is clinical depression that occurs within two years of childbirth. Due to physical, mental and emotional exhaustion combined with sleep-deprivation; motherhood can "set women up" so to speak for clinical depression. [6]
The role of anxiety in depression
Anxiety
The different types of Depression and Anxiety are classified separately by the DSM-IV-TR, with the exception of hypomania, which is included in the bipolar disorder category. Despite the different categories, depression and anxiety can indeed be co-occurring (occurring together, independently, and without mood congruence), or comorbid (occurring together, with overlapping symptoms, and with mood congruence). In an effort to bridge the gap between the DSM-IV-TR categories and what clinicians actually encounter, experts such as Herman Van Praag of Maastricht University have proposed ideas such as anxiety/aggression-driven depression [citation needed]. This idea refers to an anxiety/depression spectrum for these two disorders, which differs from the mainstream perspective of discrete diagnostic categories.
Although there is no specific diagnostic category for the comorbidity of depression and anxiety in the DSM or ICD, the National Comorbidity Survey (US) reports that 58 percent of those with major depression also suffer from lifetime anxiety. Supporting this finding, two widely accepted clinical colloquiallisms include
agitated depression - a state of depression that presents as anxiety and includes akathisia, suicide, insomnia (not early morning wakefulness), nonclinical (meaning "doesn't meet the standard for formal diagnosis") and nonspecific panic, and a general sense of dread.
akathitic depression - a state of depression that presents as anxiety or suicidality and includes akathisia but does not include symptoms of panic.
It is also clear that even mild anxiety symptoms can have a major impact on the course of a depressive illness, and the commingling of any anxiety symptoms with the primary depression is important to consider. A pilot study by Ellen Frank et al., at the University of Pittsburgh, found that depressed or bipolar patients with lifetime panic symptoms experienced significant delays in their remission. [citation needed] These patients also had higher levels of residual impairment, or the ability to get back into the swing of things. On a similar note, Robert Sapolsky of Stanford University and others also argue that the relationship between stress, anxiety, and depression could be measured and demonstrated biologically. [7]. To that point, a study by Heim and Nemeroff et al., of Emory University, found that depressed and anxious women with a history of childhood abuse recorded higher heart rates and the stress hormone ACTH when subjected to stressful situations.
Hypomania
Hypomania, as the name suggests, is a state of mind or behavior that is "below" (hypo) mania. In other words, a person in a hypomanic state often displays behavior that has all the earmarks of a full-blown mania (e.g., marked elevation of mood that is characterized by euphoria, overactivity, disinhibition, impulsivity, a decreased need for sleep, hypersexuality), but these symptoms, though disruptive and seemingly out of character, are not so pronounced as to be considered a diagnosably manic episode.
Another important point is that hypomania is a diagnostic category that includes both anxiety and depression. It often presents as a state of anxiety that occurs in the context of a clinical depression. Patients in a hypomanic state often describe a sense of extreme generalized or specific anxiety, recurring panic attacks, night terrors, guilt, and agency (as it pertains to codependence and counterdependence). All of this happens while they are in a state of retarded or somnolent depression. This is the type of depression in which a person is lethargic and unable to move through life. The terms retarded and somnolent are shorthand for states of depression that include lethargy, hypersomnia, a lack of motivation, a collapse of ADLs (activities of daily living), and social withdrawal. This is similar to the shorthand used to describe an "agitated" or "akathitic" depression.
In considering the hypomania-depression connection, a distinction should be made between anxiety, panic, and stress. Anxiety is a physiological state that is caused by the sympathetic nervous system. Anxiety does not need an outside influence to occur. Panic is related to the "fight or flight" mechanism. It is a reaction, induced by an outside stimulus, and is a product of the sympathetic nervous system and the cerebral cortex. More plainly, panic is an anxiety state that we are thinking about. Finally, stress is a psychosocial reaction, influenced by how a person filters nonthreatening external events. This filtering is based on one's own ideas, assumptions, and expectations. Taken together, these ideas, assumptions, and expectations are called social constructionism.
On a final note, researchers at the University of California, San Diego, under the guidance of Hagop Akiskal MD, have found convincing evidence for the co-occurrence of hypomanic symptoms associated with a diagnosis of depression where the diagnosis does not meet criteria for Bipolar Disorder.[citation needed] Symptoms under consideration, such as irritability, misdirected anger, and compulsivity, also may not present sufficiently to be considered a hypomanic episode, as described by a Bipolar II Disorder. As noted in the Frank study [citation needed] mentioned above, this particular course of the disease, with the breakthrough of anxiety, may have a significant impact on the overall course of the depression.
This idea of co-occurring anxiety and depresion is supported in a study by Giovanni Cassano MD of the University of Pisa and his collaborators on the Spectrum Project, who found a correlation between lifetime hypomanic and manic symptoms and the severity of the depression.[citation needed]
"The presence of a significant number of manic/hypomanic items in patients with recurrent unipolar depression seems to challenge the traditional unipolar-bipolar dichotomy."
These authors, along with many other researchers,[citation needed] argue in support of a revision of the approach to psychiatric diagnosis into what is being called the mood spectrum, so as to "[make] more accurate diagnostic evaluation[s]." This approach, although controversial, has begun to be given consideration by many behavioral health professionals.
Causes of depression
No specific cause for depression has been identified, but a number of factors are believed to be involved.
Heredity – The tendency to develop depression may be inherited; there is some evidence that this disorder may run in families. A 2004 press release from the National Institute of Mental Health declares "major depression is thought to be 40-70 percent heritable, but likely involves an interaction of several genes with environmental events." [1]
Brain chemicals called neurotransmitters allow electrical signals to move from the axon of one nerve cell to the neuron of another. A shortage of neurotransmitters impairs brain communication.Physiology – There may be changes or imbalances in chemicals that transmit information in the brain, called neurotransmitters. Many modern antidepressant drugs attempt to increase levels of certain neurotransmitters, such as serotonin and norepinephrine. Although the causal relationship is unclear, it is known that antidepressant medications can relieve certain symptoms of depression, although critics point out that the relationship between serotonin, SSRIs, and depression usually is typically greatly oversimplified when presented to the public (see here). Recent research has suggested that there may be a link between depression and neurogenesis of the hippocampus.
Seasonal affective disorder (SAD) is a type of depressive disorder that occurs in the winter when daylight hours are short. It is believed that the body's production of melatonin, which is produced at higher levels in the dark, plays a major part in the onset of SAD and that many sufferers respond well to bright light therapy, also known as phototherapy.
Psychological factors – Low self-esteem and self-defeating or distorted thinking are connected with depression. Although it is not clear which is the cause and which is the effect, it is known that depressed persons who are able to make corrections in their thinking patterns can show improved mood and self-esteem. Psychological factors related to depression include the complex development of one's personality and how one has learned to cope with external environmental factors such as stress.
Early experiences – Events such as the death of a parent, abandonment or rejection, neglect, chronic illness, and physical, psychological, or sexual abuse can also increase the likelihood of depression later in life. Post-traumatic stress disorder (PTSD) includes depression as one of its major symptoms.
Life experiences – Job loss, financial difficulties, long periods of unemployment, the loss of a spouse or other family member, divorce or the end of a committed relationship, or other traumatic events may trigger depression. Long-term stress at home, work, or school can also be involved. This is completely natural, however.
Medical conditions – Certain illnesses, including cardiovascular disease[8], hepatitis, mononucleosis, hypothyroidism, and organic brain damage caused by degenerative conditions such as Parkinson disease or by traumatic blunt force injury may contribute to depression, as may certain prescription drugs such as birth control pills and steroids. Gender dysphoria can also cause depression.
Diet – The increase in depression in industrialised societies has been linked to diet, particularly to reduced levels of omega-3 fatty acids in intensively farmed food and processed foods[9]. This link has been at least partly validated by studies using dietary supplements in schools[10] and by a double-blind test in a prison. An excess of omega-6 fatty acids in the diet was shown to cause depression in rats[11].
Alcohol and other drugs – Alcohol can have a negative effect on mood, and misuse of alcohol, benzodiazepine-based tranquilizers, and sleeping medications can all play a major role in the length and severity of depression. The link between frequent cannabis use and depression is also widely documented, although the direction of causality remains in question; Dr. Salynn Boyles writes, "...research has linked pot smoking with depression and schizophrenia ... daily use [of marijuana] was associated with a five-fold increase in later depression and anxiety among young women. But depression and anxiety were not predictive of later marijuana use." [2]
Postpartum depression (also known as postnatal depression) – Dr. Ruta M Nonacs writes that while many women experience some mood changes after giving birth, "10-15% of women experience a more disabling and persistent form of mood disturbance (eg, postpartum depression, postpartum psychosis)." [3] When it occurs, the onset typically is within three months after delivery, and it may last for several months. About two new mothers out of a thousand experience the more serious depressive disorder Postnatal Psychosis which includes hallucinations and/or delusions.
Living with a depressed person – Those living with someone suffering from depression experience increased anxiety and life disruption, increasing the possibility of also becoming depressed.
Social environment – Evolutionary theory suggests that depression is a protective mechanism: If an individual is involved in a lengthy fight for dominance of a social group and is clearly losing, depression causes the individual to back down and accept the submissive role. In doing so, the individual is protected from unnecessary harm. In this way, depression helps maintain a social hierarchy.
Other evolutionary theories – Another evolutionary theory is that the cognitive response that produces modern-day depression evolved as a mechanism that allows people to assess whether they are in pursuit of an unreachable goal. Still others claim that depression can be linked to perfectionism. People who accept satisfactory outcomes in lieu of "the best" outcome tend to lead happier lives. [citation needed]
Recently some evolutionary biologists have begun to subscribe to the theory of "honest signalling". It has been pointed out that the incidence of major depression is much higher in persons born after 1945 which would seem to cast doubt on a possible disease model and that such suffering is notable in persons of greater than average intellect and emotional complexity. This contradicts the submission thesis.
Treatment
Treatment of depression varies broadly and is different for each individual. Various types and combinations of treatments may have to be tried. There are two primary modes of treatment, typically used in conjunction: medication and psychotherapy. A third treatment, electroconvulsive therapy (ECT), may be used when chemical treatment fails.
Other alternative treatments used for depression include exercise and the use of vitamins, herbs, or other nutritional supplements.
The effectiveness of treatment often depends on factors such as the amount of optimism and hope the sufferer is able to maintain, the control s/he has over stressors, the severity of symptoms, the amount of time the sufferer has been depressed, the results of previous treatments, and the degree of support of family, friends, and significant others.
Although treatment is generally effective, in some cases the condition does not respond. Treatment-resistant depression warrants a full assessment, which may lead to the addition of psychotherapy, higher medication dosages, changes of medication or combination therapy, a trial of ECT/electroshock, or even a change in the diagnosis, with subsequent treatment changes. Although this process helps many, some people's symptoms continue unabated.
In emergencies, psychiatric hospitalization is used simply to keep suicidal people safe until they cease to be dangers to themselves. Another treatment program is partial hospitalization, in which the patient sleeps at home but spends the day, either five or seven days a week, in a psychiatric hospital setting in intense treatment. This treatment usually involves group therapy, individual therapy, psychopharmacology, and academics (in child and adolescent programs).
Medication
Medication that relieves the symptoms of depression has been available for several decades. These drugs are listed in order of historical development. Typical first-line therapy for depression is the use of an SSRI, such as sertraline (Zoloft).
Monoamine oxidase inhibitors (MAOIs) such as Nardil may be used if other antidepressant medications are ineffective. Because there are potentially fatal interactions between this class of medication and certain foods and drugs, they are rarely prescribed anymore. MAOI's are used to block the enzyme monoamine oxidase which breaks down neurotransmitters such as serotonin and norepinephrine.MAOI's are as effective as tricyclics, if not slightly more effective. A new MAOI has recently been introduced. Moclobemide (Manerix), known as a reversible inhibitor of monoamine oxidase A (RIMA), follows a very specific chemical pathway and does not require a special diet.
Tricyclic antidepressants are the oldest and include such medications as amitriptyline and desipramine. Tricyclics block the reuptake of certain neurotransmitters such as norepinephrine and serotonin. They are used less commonly now because of their side effects, which include increased heart rate, drowsiness, dry mouth,constipation, urinary retention, blurred vision,dizziness, confusion, and sexual dysfunction. Most importantly, they have a high potential to be lethal in moderate overdose. However, tricyclic antidepressants are still used because of their high potency, especially in severe cases of clinical depression.
Selective serotonin reuptake inhibitors (SSRIs) are a family of antidepressant considered to be the current standard of drug treatment. It is thought that one cause of depression is an inadequate amount of serotonin, a chemical used in the brain to transmit signals between neurons. SSRIs are said to work by preventing the reabsorption of serotonin by the nerve cell, thus maintaining the levels the brain needs to function effectively, although two researchers recently demonstrated that this is a marketing technique rather than a scientific portrayal of how the drugs actually work. [4]. Recent research indicates that these drugs may interact with transcription factors known as "clock genes"[5], which may be important for the addictive properties of drugs of abuse and possibly in obesity[6][7].
This family of drugs includes fluoxetine (Prozac), paroxetine (Paxil), escitalopram (Lexapro), citalopram (Celexa), and sertraline (Zoloft). These antidepressants typically have fewer adverse side effects than the tricyclics or the MAOIs, although such effects as drowsiness, dry mouth, nervousness, anxiety, insomnia, decreased appetite, and decreased ability to function sexually may occur. Some side effects may decrease as a person adjusts to the drug, but other side effects may be persistent.
Norepinephrine reuptake inhibitors such as reboxetine (Edronax) act via norepinephrine (also known as noradrenaline). NeRIs are thought to have a positive effect on concentration and motivation in particular.
Serotonin-norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine (Effexor) and duloxetine (Cymbalta) are a newer form of antidepressant that works on both noradrenaline and serotonin. They typically have similar side effects to the SSRIs, although there may be a withdrawal syndrome on discontinuation that may necessitate dosage tapering.
On 28 February 2006, the United States Food and Drug Administration approved Emsam, a transdermal MAOI patch developed by British company Somerset Pharmaceuticals, to be marketed in the U.S. by Bristol-Myers Squibb [8].
Dietary supplements
5-HTP supplements are claimed to provide more raw material to the body's natural serotonin production process. There is a reasonable indication that 5-HTP may not be effective for those who haven't already responded well to an SSRI.
S-adenosyl methionine (SAM-e) is a derivative of the amino acid methionine that is found throughout the human body, where it acts as a methyl donor and participates in other biochemical reactions. It is available as a prescription antidepressant in Europe and an over-the-counter dietary supplement in the United States. Clinical trials have shown SAM-e to be as effective as standard antidepressant medication, with many fewer side effects.[12],[13] Its mode of action is unknown.
Omega-3 fatty acids (found naturally in oily fish, flax seeds, hemp seeds, walnuts, and canola oil) have also been found to be effective when used as a dietary supplement (although only fish-based omega-3 fatty acids have shown antidepressant efficacy) [9].
Magnesium has gathered some attention [10][11].
St John's Wort [Hypericum Perforatum] Traditionally used by 'wise women' and midwives for hundreds of years, to 'chase away the devil' of melancholia and anxiety. It is a mood-enhancing antidepressant supplement that increases the availability of serotonin, norepinephrine and dopamine at the neuron synapses. Also popular for treating insomnia, mood swings, fatigue, PMS and menopause.[6] [12]
Ginkgo Biloba Effective natural antidepressant said to stabilise cell membranes, inhibiting lipid breakdown and aiding cell use of oxygen and glucose - so subsequently a mental and vascular stimulant that improves neaurtransmitter production. Also popular for treating mental concentration (eg for Alzheimer's and post-strokes). [6]
Siberian Ginseng [Eleutherococcus Senticosus] Although not a true panax ginseng it is a mood enhancement supplment against stress. Also popular for treating depression, insomnia, moodiness, fatigue, poor memory, lack of focus, mental tension and endurance. [6]
Zinc: 25mg per day have had an antidepressant effect [13].
Biotin: a deficiency has caused a severe depression. The patient's symptoms improved after the deficiency was corrected. [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&do pt=Abstract&list_uids=6406708&query_hl=2&itool=pubmed_docsum]
The amino acids phenylalanine and tyrosine have also a favourabele effect by easy forms of depression. They enhance the neurotransmitters dopamine and noradrenalin.
Augmentor drugs
Some antidepressants have been found to work more effectively in some patients when used in combination with another drug. Such "augmentor" drugs include tryptophan (Tryptan) and buspirone (Buspar).
Tranquillizers and sedatives, typically the benzodiazepines, may be prescribed to ease anxiety and promote sleep. Because of their high potential for fostering dependence, these medications are intended only for short-term or occasional use. Medications often are used not for their primary function but to exploit what are normally side effects. Quetiapine fumarate (Seroquel) is designed primarily to treat schizophrenia and bipolar disorder, but a frequently reported side-effect is somnolence. Therefore, this drug can be used in place of an antianxiety agent such as clonazepam (Klonopin, Rivotril).
Antipsychotics such as risperidone (Risperdal), olanzapine (Zyprexa), and Quetiapine (Seroquel) are prescribed as mood stabilizers and are also effective in treating anxiety. Their use as mood stabilizers is a recent phenomenon and is controversial with some patients. Antipsychotics (typical or atypical) may be also prescribed in an attempt to augment an antidepressant, to make antidepressant blood concentration higher, or to relieve psychotic or paranoid symptoms often accompanying clinical depression. However, they may have serious side effects, particularly at high dosages, which may include blurred vision, muscle spasms, restlessness, tardive dyskinesia, and weight gain.
Antidepressants by their nature are stimulants. Antianxiety medications by their nature are depressants. Close medical supervision is critical to proper treatment if a patient presents with both illnesses because the medications tend to work against each other.
Lithium remains the standard treatment for bipolar disorder and is often used in conjunction with other medications, depending on whether mania or depression is being treated. Lithium's potential side effects include thirst, tremors, light-headedness, and nausea or diarrhea. Some of the anticonvulsants, such as carbamazepine (Tegretol), sodium valproate (Epilim), and lamotrigine (Lamictal), are also used as mood stabilizers, particularly in bipolar disorder.
Failure to take medication or failure to take it as prescribed is one of the major causes of relapse. Should one feel a change or discontinuation of medication is necessary, it is critical that this be done in consultation with a doctor.
Psychotherapy
In psychotherapy, or counseling, one receives assistance in understanding and resolving problems that may be contributing to depression. This may be done individually or with a group and is conducted by health professionals such as psychiatrists, psychologists, social workers, or psychiatric nurses. It is important to ask about the therapist's training and approach; a very close bond often forms between practitioner and client, and it is important that the client feel understood by the clinician.
Counselors can help a person make changes in thinking patterns, deal with relationship problems, detect and deal with relapses, and understand the factors that contribute to depression.
There are many therapeutic approaches, but all are aimed at improving one's personal and interpersonal functioning. Cognitive therapy, also known as Cognitive Behavior Therapy, focuses on how people think about themselves and their relationships. It helps depressed people learn to replace negative depressive thoughts with positive ones, as well as develop more effective coping behaviors and skills. Therapy can be used to help a person develop or improve interpersonal skills in order to allow him or her to communicate more effectively and reduce stress. Interpersonal psychotherapy focuses on the social and interpersonal triggers that cause their depression. Narrative therapy gives attention to each person's "dominant story" by means of therapeutic conversations, which also may involve exploring unhelpful ideas and how they came to prominence. Possible social and cultural influences may be explored if the client deems it helpful. Behavioral therapy is based on the assumption that behaviors are learned. This type of therapy attempts to teach people more healthful types of behaviors. Supportive therapy encourages people to discuss their problems and provides them with emotional support. The focus is on sharing information, ideas, and strategies for coping with daily life. Family therapy helps people live together more harmoniously and undo patterns of destructive behavior.
Transcranial magnetic stimulation
Repetitive transcranial magnetic stimulation (rTMS) is under study as a possible treatment for depression. Initially designed as a tool for physiological studies of the brain, this technique shows promise as a means of alleviating depression. In this therapy, a powerful magnetic field is used to stimulate the left prefrontal cortex, an area of the brain that typically shows abnormal activity in depressed people.
rTMS has been proposed as an alternative to ECT that would have fewer side effects. No sedation is needed, and the only reported side effects are a slight headache in some patients and facial muscle contraction during treatment. However, clear evidence that it is effective is still awaited.[14]
Recent work in Poland suggested that weak, variable magnetic fields may offer relief from depression in those who have not responded to medication. However, some of the existing work has been questioned, with claims that the effect is not as significant once environmental conditions are controlled for.
Vagus nerve stimulation
Vagus nerve stimulation therapy is a treatment used since 1997 to control seizures in epileptic patients and has recently been approved for treating resistant cases of clinical depression. The VNS device is implanted in a patient's chest with wires that connect it to the vagus nerve, which it stimulates to reach a region of the brain associated with moods. The device delivers controlled electrical currents to the vagus nerve at regular intervals.
Electroconvulsive therapy
Electroconvulsive therapy (ECT), also known as electroshock or electroshock therapy, uses short bursts of a controlled current of electricity (typically fixed at 0.9 ampere) into the brain to induce a brief, artificial seizure while the patient is under general anesthesia.
ECT has acquired a fearsome reputation, in part from its use as a tool of repression in the former USSR and its fictional depiction in films such as One Flew Over the Cuckoo's Nest, but remains a common treatment where other means of treatment have failed or where the use of drugs is unacceptable (as in pregnancy). Also, in contrast to direct electroshock of years ago, most countries now allow ECT to be administered only under anaesthesia. In a typical regimen of treatment, a patient receives three treatments per week over three or four weeks. Repeat sessions may be needed. Short-term memory loss, disorientation, and headache are very common side effects. In some cases, permanent memory loss has occurred, but detailed neuropsychological testing in clinical studies has not been able to prove permanent effects on memory. ECT offers the benefit of a very fast response; however, this response has been shown not to last unless maintenance electroshock or maintenance medication is used. Whereas antidepressants usually take around a month to take effect, the results of ECT have been shown to be much faster. For this reason, it is the treatment of choice in emergencies (e.g., in catatonic depression in which the patient has ceased oral intake of fluid or nutrients).
There remains much controversy over electroshock. Advocacy groups and scientific critics, such as Dr Peter Breggin[14], call for restrictions on its use or complete abolishment. Like all forms of psychiatric treatment, electroshock can be given without a patient's consent, but this is subject to legal conditions dependent on the jurisdiction.
Other methods of treatment
Light therapy
Bright light (both sunlight and artificial light) is shown to be effective in seasonal affective disorder, and sometimes may be effective in other types of depression, especially atypical depression or depression with "seasonal phenotype" (overeating, oversleeping, weight gain, apathy).
Important note: An antidepressant effect is caused by stimulation of the retina by the visible light, not by the ultra-violet portion. Thus, it is not necessary (and may be even dangerous in some cases) to get sunburn. It can be enough just to walk at daytime or to take light therapy using a light box. However, recent discoveries of the existence and importance of the third kind of photoreceptor in our eyes, the intrinsically photosensitive retinal ganglion cells (ipRGC), critical to human chronobiology, strongly suggest that bluish light is more helpful, and manufacturers are beginning to respond to this finding.[citation needed]
Exercise
It is widely believed that physical activity and exercise help depressed patients and promote quicker and better relief from depression. They are also thought to help antidepressants and psychotherapy work better and faster. It can be difficult to find the motivation to exercise if the depression is severe, but sufferers should be encouraged to take part in some form of regularly scheduled physical activity. A workout need not be strenuous; many find walking, for example, to be of great help. Exercise produces higher levels of chemicals in the brain, notably dopamine, serotonin, and norepinephrine. In general this leads to improvements in mood, which is effective in countering depression.
Note that before beginning an exercise regime, it is wise to consult a doctor. He or she can establish whether a person has any health problems that could contraindicate some types of exercise.
Meditation
Meditation is increasingly seen as a useful treatment for depression. The current professional opinion on meditation is that it represents at least a complementary method of treating depression, a view that has been clearly underscored by the Mayo Clinic. Since the late 1990s, much research has been carried out to determine how meditation affects the brain (for more information see the main article on meditation). Although the effects on the mind are complex, they are often quite positive, encouraging a calm, reflective, and rational state of mind that can be of great help against depression. Although many religions include meditative practice, it is not necessary to be a member of any faith to meditate.
Old methods
Insulin shock therapy is an old and largely abandoned treatment of severe depressions, psychoses, catatonic states, and other mental disorders. It consists of induction of hypoglycemic coma by intravenous infusion of insulin. The treatment is potentially unsafe and can be lethal in some cases (about 1% of patients undergoing insulin coma), even with proper monitoring. In contrast, ECT is considered to be very safe.
Nevertheless, insulin shock therapy is still officially used in Russia and some other countries and can be administered to a very treatment-resistant patient with written consent in many Western countries.
Atropinic shock therapy, also known as atropinic coma therapy, is an old and rarely used method. It consists of induction of atropinic coma by rapid intravenous infusion of atropine.
Atropinic shock treatment is considered safe, but it entails prolonged coma (4-5 hours), with careful monitoring and preparation, and it has many unpleasant side effects, such as blurred vision. It can be used with written consent in Western countries in very treatment-resistant patients and is still officially used in Russia and some other countries.
Adverse reactions
Aspartame was associated with a significant difference in number and severity of symptoms for patients with a history of depression in an experiment [15].
Relapse
Relapse is more likely if treatment has not resulted in full remission of symptoms.4 In fact, current guidelines for antidepressant use recommend 4 to 6 months of continuing treatment after symptom resolution to prevent relapse.
Combined evidence from many randomized controlled trials indicates that continuing antidepressant medications after recovery substantially reduces (halves) the chances of relapse. This preventive effect probably lasts for at least the first 36 months of use.[15]
Anecdotal evidence suggests that chronic disease is accompanied by relapses after prolonged treatment with antidepressants (Tachyphylaxis). Psychiatric texts suggest that physicians respond to relapses by increasing dosage, complementing the medication with a different class, or changing the medication class entirely. The reason for relapse in these cases is as poorly understood as the change in brain physiology induced by the medications themselves. Possible reasons may include aging of the brain or worsening of the condition. Most SSRI psychiatric medications were developed for short-term use (a year or less) but are widely prescribed for indefinite periods.[16]
Social attitudes to depression
Employment
High-stress employers are sometimes reluctant to consider hiring people with a history of depression, but not doing so could be seen as a form of illegal discrimination. For instance, the US military standards do not allow more than six months of treatment for depression before someone becomes ineligible. However, a waiver is possible in some circumstances
Sertraline(zoloft)
From Wikipedia, the free encyclopedia
(Redirected from Zoloft)
Contents [hide]
1 Uses
2 Side effects
3 Forms and dosages
4 Precautions
5 Dopamine
6 Controversy
7 Patent Loss
Uses
Sertraline is used medically mainly to treat the symptoms of depression and anxiety. It has also been prescribed for the treatment of obsessive-compulsive disorder, post-traumatic stress disorder, premenstrual dysphoric disorder, panic disorder, and bipolar disorder. It was first approved by the FDA in 1991. The patent for this brand-name drug expired in December 2005. It is anticipated that the generic drug will be available in the United States in June of 2006, manufactured by Andrx, Aurobindo, Genpharm, Ivax, Mylan, and Roxane. In Scandinavia a generic drug called Sertralin, manufactured by HEXAL is available. The price differences between Zoloft® and Sertralin® are as high as 1.50 dollars per pill.
Side effects
Sertraline can have a number of adverse effects, including insomnia, asthenia, gastrointestinal complaints, tremors, confusion, dizziness, anorgasmia, and decreased libido; it can induce mania or hypomania in around 0.5% of patients. It has also been known to cause minor weight loss. It is contraindicated in individuals taking MAOIs or undergoing electroconvulsive therapy.
Forms and dosages
Zoloft logoSertraline is manufactured by Pfizer and sold as Zoloft in the United States as small green 25 mg tablets, blue 50 mg tablets, and yellow 100 mg tablets (Generic 100mg sertraline tablets are also yellow), each of which is scored to allow easy halving. In the UK, the brand name is Lustral and is available in white 50mg or 100mg tablets, according to the British National Formulary BNF. In Australia, only the 50 mg and 100 mg strengths are available, both as white tablets. Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is 50 mg per day, but lower doses may be used in the initial weeks of treatment to acclimate the patient's body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day.
Precautions
Because of its metabolism, liver impairment can affect the elimination of this drug from the body. If someone with liver impairment is treated with sertraline, lower or less frequent dosage should be used. Similarly, patients should limit their alcohol intake while on sertraline (or any antidepressant). Because the liver is doubly taxed with processing both substances (in addition to any other drugs the patient may be taking), alcohol remains in the bloodstream longer, so the effects of alcohol may be more strongly and quickly felt by people taking sertraline or other antidepressants. According to some studies grapefruit juice might interfere with the metabolisation of sertraline, increasing its concentration in the blood.
Dopamine
One property of sertraline is that it appears to be also a minor inhibitor of dopamine reuptake. At higher dosages (300 mg/day), sertraline inhibits the reuptake of dopamine as well as serotonin.
Controversy
In June 2003, Britain banned the use of sertraline for children under 18 after studies showed a link to increasing suicidal rates. Similar concern has prevailed in the United States, where only the anti-depressant fluoxetine (another SSRI) was officially banned by the FDA for the treatment of depression in minors. However, because the antidepressant-suicide link is correlational, scientists do not know whether the increased suicide risk for people taking antidepressants occurs because the drugs make people suicidal, whether suicide occurs because the drugs un-depress the people enough to motivate the energy required to commit suicide (a popular theory), or because of a third, unknown factor.
Patent Loss
Pfizer will lose their patent protection for Zoloft later in 2006.[1]